C3-targeted Therapy in Periodontal Disease: Moving Closer to the Clinic

Overview

Journal Trends Immunol

Specialty Allergy & Immunology

Date 2021 Sep 6

PMID 34483038

Citations 23

Authors

George Hajishengallis

Hatice Hasturk

John D Lambris

Affiliations

Soon will be listed here.

Abstract

Complement plays a key role in immunosurveillance and homeostasis. When dysregulated or overactivated, complement can become a pathological effector, as seen in several inflammatory disorders, including periodontal disease. Recently, clinical correlative studies and preclinical mechanistic investigations have collectively demonstrated that complement is hyperactivated during periodontitis and that targeting its central component (C3) provides therapeutic benefit in nonhuman primates (NHPs). The preclinical efficacy of a C3-targeted drug candidate combined with excellent safety and pharmacokinetic profiles supported its use in a recent Phase IIa clinical study in which C3 inhibition resolved gingival inflammation in patients with periodontal disease. We posit that C3-targeted intervention might represent a novel and transformative host-modulation therapy meriting further investigation in Phase III clinical trials for the treatment of periodontitis.

Citing Articles

Population Proteomics: A Tool to Gain Insights Into the Inflamed Periodontium.

Reckelkamm S, Baumeister S, Hagenfeld D, Alayash Z, Nolde M Proteomics. 2024; 25(1-2):e202400055.

PMID: 39740164 PMC: 11735663. DOI: 10.1002/pmic.202400055.

Direct Immunofluorescence in Oral Lichen Planus and Related Lesions: Sensitivity, Specificity, and Diagnostic Accuracy in a Single Diagnostic Center in Poland.

Osipowicz K, Szymanski K, Pietrzyk E, Milczarek E, Kowalewski C, Gorska R Dent J (Basel). 2024; 12(12).

PMID: 39727453 PMC: 11674106. DOI: 10.3390/dj12120396.

Identify novel therapeutic targets for type II diabetes and periodontitis: insights from single-cell analysis and Mendelian randomization analysis.

Zou M, Yang J Front Endocrinol (Lausanne). 2024; 15:1410537.

PMID: 39544234 PMC: 11560462. DOI: 10.3389/fendo.2024.1410537.

Analyzing Pooled Microarray Gene Expression Data to Uncover Common Pathways in Periodontitis and Oral Squamous Cell Carcinoma from the Gene Expression Omnibus.

Karri R, Amrutha R, Shrinivas , Bojji M, Kumar K, Benarji K J Pharm Bioallied Sci. 2024; 16(Suppl 2):S1515-S1521.

PMID: 38882729 PMC: 11174343. DOI: 10.4103/jpbs.jpbs_1180_23.

Mass Spectrometry-Based Proteomics for Discovering Salivary Biomarkers in Periodontitis: A Systematic Review.

Hu H, Leung W Int J Mol Sci. 2023; 24(19).

PMID: 37834046 PMC: 10572407. DOI: 10.3390/ijms241914599.

References

Allam J, Duan Y, Heinemann F, Winter J, Gotz W, Deschner J . IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol. 2011; 38(10):879-86. DOI: 10.1111/j.1600-051X.2011.01752.x. View

Kassebaum N, Bernabe E, Dahiya M, Bhandari B, Murray C, Marcenes W . Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 2014; 93(11):1045-53. PMC: 4293771. DOI: 10.1177/0022034514552491. View

Courts F, Boackle R, Fudenberg H, Silverman M . Detection of functional complement components in gingival crevicular fluid from humans with periodontal diseases. J Dent Res. 1977; 56(3):327-31. DOI: 10.1177/00220345770560032001. View

Botelho J, Machado V, Leira Y, Proenca L, Chambrone L, Mendes J . Economic burden of periodontitis in the United States and Europe: An updated estimation. J Periodontol. 2021; 93(3):373-379. DOI: 10.1002/JPER.21-0111. View

Abe T, Hosur K, Hajishengallis E, Reis E, Ricklin D, Lambris J . Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist. J Immunol. 2012; 189(11):5442-8. PMC: 3504137. DOI: 10.4049/jimmunol.1202339. View

Qu H, Ricklin D, Bai H, Chen H, Reis E, Maciejewski M . New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology. 2012; 218(4):496-505. PMC: 3518557. DOI: 10.1016/j.imbio.2012.06.003. View

Chapple I . Time to take periodontitis seriously. BMJ. 2014; 348:g2645. DOI: 10.1136/bmj.g2645. View

Schenkein H, Papapanou P, Genco R, Sanz M . Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000. 2020; 83(1):90-106. DOI: 10.1111/prd.12304. View

Dutzan N, Kajikawa T, Abusleme L, Greenwell-Wild T, Zuazo C, Ikeuchi T . A dysbiotic microbiome triggers T17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med. 2018; 10(463). PMC: 6330016. DOI: 10.1126/scitranslmed.aat0797. View

10.

Hajishengallis G, Chavakis T . Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021; 21(7):426-440. PMC: 7841384. DOI: 10.1038/s41577-020-00488-6. View

11.

Peres M, Macpherson L, Weyant R, Daly B, Venturelli R, Mathur M . Oral diseases: a global public health challenge. Lancet. 2019; 394(10194):249-260. DOI: 10.1016/S0140-6736(19)31146-8. View

12.

Freeley S, Kemper C, Le Friec G . The "ins and outs" of complement-driven immune responses. Immunol Rev. 2016; 274(1):16-32. PMC: 5102160. DOI: 10.1111/imr.12472. View

13.

Brauchle F, Noack M, Reich E . Impact of periodontal disease and periodontal therapy on oral health-related quality of life. Int Dent J. 2014; 63(6):306-11. PMC: 9375002. DOI: 10.1111/idj.12042. View

14.

Frencken J, Sharma P, Stenhouse L, Green D, Laverty D, Dietrich T . Global epidemiology of dental caries and severe periodontitis - a comprehensive review. J Clin Periodontol. 2017; 44 Suppl 18:S94-S105. DOI: 10.1111/jcpe.12677. View

15.

Hajishengallis G, Kajikawa T, Hajishengallis E, Maekawa T, Reis E, Mastellos D . Complement-Dependent Mechanisms and Interventions in Periodontal Disease. Front Immunol. 2019; 10:406. PMC: 6422998. DOI: 10.3389/fimmu.2019.00406. View

16.

Kinane D, Stathopoulou P, Papapanou P . Periodontal diseases. Nat Rev Dis Primers. 2017; 3:17038. DOI: 10.1038/nrdp.2017.38. View

17.

Ley K, Hoffman H, Kubes P, Cassatella M, Zychlinsky A, Hedrick C . Neutrophils: New insights and open questions. Sci Immunol. 2018; 3(30). DOI: 10.1126/sciimmunol.aat4579. View

18.

Miller D, McDowell J, Bell J, Goetting-Minesky M, Fenno J, Marconi R . Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease. Mol Oral Microbiol. 2014; 29(5):194-207. PMC: 4165728. DOI: 10.1111/omi.12054. View

19.

Niekrash C, Patters M . Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease. J Periodontal Res. 1986; 21(3):233-42. DOI: 10.1111/j.1600-0765.1986.tb01455.x. View

20.

Lamont R, Koo H, Hajishengallis G . The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018; 16(12):745-759. PMC: 6278837. DOI: 10.1038/s41579-018-0089-x. View